CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 55 filers reported holding CYTEK BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $152,060 | +32.4% | 17,028 | +50.5% | 0.01% | +14.3% |
| Q1 2023 | $114,878 | -41.3% | 11,318 | -22.1% | 0.01% | -41.7% |
| Q4 2022 | $195,652 | -6.8% | 14,525 | +1.8% | 0.01% | -20.0% |
| Q3 2022 | $210,000 | +40.9% | 14,270 | +22.7% | 0.02% | +36.4% |
| Q2 2022 | $149,000 | +40.6% | 11,626 | +5.4% | 0.01% | +37.5% |
| Q1 2022 | $106,000 | -30.7% | 11,030 | +4.5% | 0.01% | -27.3% |
| Q4 2021 | $153,000 | -27.8% | 10,560 | +13.3% | 0.01% | -26.7% |
| Q3 2021 | $212,000 | – | 9,323 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |